Study participants A total of 18 individuals were enrolled in the study—11 with relapsing-remitting MS, ...
GLP-1 drugs are not approved to treat MS; they can’t and should not replace MS ...
Marit G, Boiron JM, Reiffers J. Autologous blood stem cell transplantation in high risk myeloma. ...
A recent publication by Qin et al. in Cell reported on the first-in-human application of ...